全文获取类型
收费全文 | 15966篇 |
免费 | 1262篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 304篇 |
儿科学 | 353篇 |
妇产科学 | 226篇 |
基础医学 | 2017篇 |
口腔科学 | 538篇 |
临床医学 | 1525篇 |
内科学 | 3216篇 |
皮肤病学 | 204篇 |
神经病学 | 1750篇 |
特种医学 | 594篇 |
外科学 | 2327篇 |
综合类 | 251篇 |
一般理论 | 10篇 |
预防医学 | 1423篇 |
眼科学 | 272篇 |
药学 | 1097篇 |
1篇 | |
中国医学 | 9篇 |
肿瘤学 | 1156篇 |
出版年
2023年 | 87篇 |
2022年 | 127篇 |
2021年 | 281篇 |
2020年 | 206篇 |
2019年 | 234篇 |
2018年 | 302篇 |
2017年 | 236篇 |
2016年 | 245篇 |
2015年 | 255篇 |
2014年 | 396篇 |
2013年 | 678篇 |
2012年 | 891篇 |
2011年 | 973篇 |
2010年 | 566篇 |
2009年 | 559篇 |
2008年 | 978篇 |
2007年 | 1015篇 |
2006年 | 1066篇 |
2005年 | 1012篇 |
2004年 | 987篇 |
2003年 | 991篇 |
2002年 | 981篇 |
2001年 | 172篇 |
2000年 | 121篇 |
1999年 | 157篇 |
1998年 | 220篇 |
1997年 | 204篇 |
1996年 | 199篇 |
1995年 | 166篇 |
1994年 | 143篇 |
1993年 | 107篇 |
1992年 | 122篇 |
1991年 | 113篇 |
1990年 | 108篇 |
1989年 | 83篇 |
1988年 | 99篇 |
1987年 | 88篇 |
1986年 | 94篇 |
1985年 | 103篇 |
1984年 | 127篇 |
1983年 | 140篇 |
1982年 | 167篇 |
1981年 | 145篇 |
1980年 | 156篇 |
1979年 | 81篇 |
1978年 | 128篇 |
1977年 | 100篇 |
1976年 | 105篇 |
1974年 | 77篇 |
1973年 | 66篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Diabetes mellitus(DM) negatively affects the development and progression of chronic liver diseases(CLD) of various etiologies. Concurrent DM and CLD are also associated with worse clinical outcomes with respect to mortality, the occurrence of hepatic decompensation, and the development of hepatocellular carcinoma(HCC). Unfortunately, early diagnosis and optimal treatment of DM can be challenging, due to the lack of established clinical guidelines as well as the medical complexity of this patient population. We conducted an exploratory review of relevant literature to provide an up-to-date review for internists and hepatologists caring for this patient population. We reviewed the epidemiological and pathophysiological associations between DM and CLD, the impact of insulin resistance on the progression and manifestations of CLD, the pathogenesis of hepatogenic diabetes, as well as the practical challenges in diagnosis and monitoring of DM in this patient population. We also reviewed the latest clinical evidence on various pharmacological antihyperglycemic therapies with an emphasis on liver disease-related clinical outcomes. Finally, we proposed an algorithm for managing DM in patients with CLD and discussed the clinical and research questions that remain to be addressed. 相似文献
6.
7.
8.
S. Vitko Z. Wlodarczyk L. Kyllönen Z. Czajkowski R. Margreiter L. Backman F. Perner P. Rigotti B. Jaques D. Abramowicz M. Kessler J. Sanchez-Plumed L. Rostaing R.S. Rodger D. Donati Y. Vanrenterghem 《American journal of transplantation》2006,6(3):531-538
Tacrolimus combined with mycophenolate mofetil (MMF) is an effective regimen in kidney transplantation. This study compared the efficacy of combining tacrolimus and two different dosages of sirolimus with an established tacrolimus-MMF regimen. Each day in addition to tacrolimus, 325 patients received 2 mg sirolimus (TAC-SRL2 mg), 325 patients received 0.5 mg sirolimus (TAC-SRL0.5 mg) and 327 patients 1 g MMF (TAC-MMF). The initial tacrolimus dose was 0.2 mg/kg/day. Sirolimus patients received loading doses of 6 or 1.5 mg, and daily doses of 2 or 0.5 mg thereafter. Steroid administration was identical for all groups. The incidence of biopsy-proven acute rejection was lower in the TAC-SRL2 mg group (15.7%) compared with the TAC-SRL0.5 mg (25.2%, p = 0.003) and the TAC-MMF groups (22.3%, p = 0.036). Six-month graft survival was 91.0% (TAC-SRL2 mg), 92.6% (TAC-SRL0.5 mg) and 92.4% (TAC-MMF); the respective values for patient survival were 98.1%, 97.8% and 97.9%. Thirty-four patients (10.5%), 19 patients (5.8%) and 16 patients (4.9%) in the TAC-SRL2 mg, TAC-SRL0.5 mg and TAC-MMF groups, respectively, discontinued the study because of adverse events. Hyperlipemia was reported more often in the TAC-SRL2 mg group (24.0%) compared with 19.4% (TAC-SRL0.5 mg) and 11.0% (TAC-MMF; p < 0.05). Combining 2 mg sirolimus/day with tacrolimus results in lower rates of acute rejection, but a higher incidence of adverse events. 相似文献
9.
10.
蒿甲醚引起小鼠体内日本血吸虫和曼氏血吸虫皮层变化1肖树华,沈炳贵,JackHORNER2,BrianACATTO3(中国预防医学科学院寄生虫病研究所,世界卫生组织疟疾、血吸虫病和丝虫病合作中心,上海200025,中国;2DepartmentofCli... 相似文献